BUZZ — PREVIEW: Johnson & Johnson earnings expected to decline in Q3
* Johnson & Johnson shares up 0.6% at $263.00 on Mon ahead of qtrly results before the bell, with investors watching for a rebound in its medtech unit * The healthcare conglomerate is expected to post Q3 rev of $25.28 bln and adj EPS of $2.54, down from EPS of $2.80 but up from revenue of $23.99 bln a year ago, per LSE